InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-65.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Astor Andrew, Chief Executive Officer. Director active across 1 company, notably NEPHROS INC. Aggregated, 3 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €33k. History available since 17 August 2021. The latest transaction was filed on 5 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
14,815 shares@ US$2.700.070% mcap52.5% of flowCommon StockSEC:0001437749-22-005408:0
2,500 shares@ US$7.668723.8% of flowCommon StockSEC:0000914190-21-000282
Ideal exit: 14 May 2022 (T+270)
2,500 shares@ US$7.66870.032% mcap23.8% of flowCommon StockSEC:0000914190-21-000282:0
Ideal exit: 14 May 2022 (T+270)
3 of 3 declarations
About Astor Andrew
Andrew Astor is the President and CEO of Nephros Inc. He oversees the company's operations and strategy, focusing on innovation in water purification technologies. His role is crucial in ensuring growth and development of public health solutions.
